National Bank of Canada
NMTR

National Bank of Canada’s 9 Meters Biopharma NMTR Stock Holding History

National Bank of Canada’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-650
Closed -$3K – 2954
2022
Q2 		$3K Hold
650
– – ﹤0.01% 2572
2022
Q1 		$8K Hold
650
– – ﹤0.01% 2451
2021
Q4 		$13K Buy
+650
New +$14.5K ﹤0.01% 2287

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

National Bank of Canada's NMTR Position: Q3 2022 in Review

National Bank of Canada sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 650 shares — an estimated $3K sold.

National Bank of Canada first reported a position in NMTR in Q4 2021 and held it in 3 quarters. The position peaked at $13K in Q4 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • National Bank of Canada reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • National Bank of Canada sold 650 9 Meters Biopharma shares in Q3 2022, an estimated $3K.
  • National Bank of Canada first reported a position in 9 Meters Biopharma in Q4 2021 and held it in 3 quarters.
  • National Bank of Canada's 9 Meters Biopharma position peaked at $13K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on National Bank of Canada's 13F filing for Q3 2022, filed 13 Oct 2022.